4//SEC Filing
Olson Eric R 4
Accession 0001209191-23-011165
CIK 0001556263other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:23 PM ET
Size
5.7 KB
Accession
0001209191-23-011165
Insider Transaction Report
Form 4
Olson Eric R
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2023-02-16+35,000→ 35,000 total→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F2]These RSUs will vest as to one third (1/3rd) of the shares underlying the award on March 31, 2024 and as to an additional one third (1/3rd) of such shares at the end of each successive year thereafter.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001678149
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:23 PM ET
- Size
- 5.7 KB